Psychotherapy for obsessive-compulsive disorder
- PMID: 19635238
- DOI: 10.1007/s11920-009-0043-8
Psychotherapy for obsessive-compulsive disorder
Abstract
Cognitive-behavioral therapy (CBT) with exposure and response prevention is a first-line intervention for adult and childhood obsessive-compulsive disorder. Methodologically rigorous controlled trials have suggested that benefits from CBT exceed those from placebo and attention-control conditions and have similar or greater efficacy than serotonergic monotherapy. This article reviews the nature of CBT and associated outcome data, highlighting recent empiric findings in the treatment literature.
Similar articles
-
Efficacy of Augmentation of Cognitive Behavior Therapy With Weight-Adjusted d-Cycloserine vs Placebo in Pediatric Obsessive-Compulsive Disorder: A Randomized Clinical Trial.JAMA Psychiatry. 2016 Aug 1;73(8):779-88. doi: 10.1001/jamapsychiatry.2016.1128. JAMA Psychiatry. 2016. PMID: 27367832 Free PMC article. Clinical Trial.
-
A preliminary study of D-cycloserine augmentation of cognitive-behavioral therapy in pediatric obsessive-compulsive disorder.Biol Psychiatry. 2010 Dec 1;68(11):1073-6. doi: 10.1016/j.biopsych.2010.07.015. Biol Psychiatry. 2010. PMID: 20817153 Free PMC article. Clinical Trial.
-
D-Cycloserine vs Placebo as Adjunct to Cognitive Behavioral Therapy for Obsessive-Compulsive Disorder and Interaction With Antidepressants: A Randomized Clinical Trial.JAMA Psychiatry. 2015 Jul;72(7):659-67. doi: 10.1001/jamapsychiatry.2015.0546. JAMA Psychiatry. 2015. PMID: 25970252 Clinical Trial.
-
Factors associated with poor response in cognitive-behavioral therapy for pediatric obsessive-compulsive disorder.Bull Menninger Clin. 2010 Spring;74(2):167-85. doi: 10.1521/bumc.2010.74.2.167. Bull Menninger Clin. 2010. PMID: 20545494 Review.
-
[Psychotherapy for obsessive-compulsive disorder: what is evidence based?].Nervenarzt. 2011 Mar;82(3):308-10, 312, 314-6, passim. doi: 10.1007/s00115-010-2962-3. Nervenarzt. 2011. PMID: 21347694 Review. German.
Cited by
-
Therapies for obsessive-compulsive disorder: Current state of the art and perspectives for approaching treatment-resistant patients.Front Psychiatry. 2023 Feb 16;14:1065812. doi: 10.3389/fpsyt.2023.1065812. eCollection 2023. Front Psychiatry. 2023. PMID: 36873207 Free PMC article. Review.
-
Obsessive-compulsive disorder: a review of the diagnostic criteria and possible subtypes and dimensional specifiers for DSM-V.Depress Anxiety. 2010 Jun;27(6):507-27. doi: 10.1002/da.20669. Depress Anxiety. 2010. PMID: 20217853 Free PMC article. Review.
-
Excluding the typical patient: thirty years of pharmacotherapy efficacy trials for obsessive-compulsive disorder.Ann Clin Psychiatry. 2014 Feb;26(1):39-46. Ann Clin Psychiatry. 2014. PMID: 24501729 Free PMC article. Review.
-
D-cycloserine augmentation in behavioral therapy for obsessive-compulsive disorder: a meta-analysis.Drug Des Devel Ther. 2015 Apr 21;9:2101-17. doi: 10.2147/DDDT.S68994. eCollection 2015. Drug Des Devel Ther. 2015. PMID: 25960632 Free PMC article. Review.
-
Innovations in the Delivery of Exposure and Response Prevention for Obsessive-Compulsive Disorder.Curr Top Behav Neurosci. 2021;49:301-329. doi: 10.1007/7854_2020_202. Curr Top Behav Neurosci. 2021. PMID: 33590457
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical